---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047196"
form_type: "8-K"
ticker: "NRXS"
cik: "0001933567"
company_name: "Neuraxis, INC"
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T21:18:36.326644+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Neuraxis amends Series B Preferred terms: extends dividends, increases authorized shares, revises voting rights

## Summary
- Increased authorized Series B Preferred shares from 4,000,000 to 5,000,000.
- Extended 8.5% annual dividend right by 18 months, now through December 31, 2026.
- Amended voting rights: each Series B share votes equal to common shares convertible at $3.80 per share.

## SEC filing metadata
- accession: 0001493152-24-047196
- form_type: 8-K
- ticker: NRXS
- cik: 0001933567
- company_name: Neuraxis, INC
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1933567/000149315224047196/0001493152-24-047196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1933567/000149315224047196/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047196
- JSON: https://secwatch.observer/filing/0001493152-24-047196.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.